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In kidney cortex tubules isolated from fed rabbits L-alanine is not utilized as giucose precursor, when added as a sole substrate. However, this 
amino acid decreases glucon#~nesis from low (up to 1 mM) ‘2-oxoglutarate concentrations and stimulates this process at higher (2.5-10 mM) 
ketoacid contents in the suspension medium. Aminooxyacetate, an inhibitor of aminotransferases, abolishes both inhibitory and stimulatory effects 
of L-alanine on glucose formation. The addition of 2-oxoglutarate increases the incorporation of L-I[J-V]alanine to glucose from 8- to 123-fold, 
depending upon the ketoacid and alanine concentrations used. In contrast, nonlabelled L-alanine decreases the incorporation of low p-14C)2-oxo- 
glutarate concentrations into glucose, while it does not affect contribution of 5 mM ketoacid to gluconeogenesis. The data indicate that (i) in the 
presence of 2-oxoglutarate L-alanine is utilized as glucose precursor in rabbit renal tubules and (ii) this amino acid may decrease the contribution 
of low extracellular concentrations of the ketoacid to gluconeogenesis. 
Alanine; Gluconeogenesis; (Rabbit renal tubule) 
1, INTRODUCTION 
Although alanine aminotransferase is located in the 
straight portion of proximal nephron [l] it has been 
shown that in contrast to the rat perfused liver 121 and 
isolated hepatocytes [3,4], L-alanine is not used as 
glucose precursor in rat kidney cortex slices [5] and 
isolated renal cortex tubules derived from rat [6] and 
guinea pig [7]. Alanine does, however, exert a 
stimulatory effect on glucose synthesis from pyruvate 
and lactate in rat renal cortical tubules, probabIy due to 
an inhibition of pyruvate kinase activity by this amino 
acid [6], a potent inhibitor of the enzyme [8]. 
It is established that the major role of alanine in renal 
metabolism reside in its production by renal tubules [9]. 
However, Michoudet et al. [IO] have recently reported 
that in guinea pig renal cortex tubules alanine may be 
converted into glutamine with the use of pyruvate car- 
boxylase which catalyses the fixation of CO;! on 
pyruvate to give oxaloacetate for synthesis of citrate 
and then of aconitate and 2-oxoglutarate. Moreover, as 
concluded from 13C-NMR studies with the use of renal 
epithelial cells [ 111, 13C label from L-[13C]alanine may 
enter tricarboxylic acid cycle through both pyruvate 
dehydrogenase and pyruvate carboxylase pathways, 
giving rise to 13C-labelled glutamate. Since pyruvate 
carboxylase is the first enzyme of gluconeogenesis, 
studies were undertaken to establish conditions for 
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glucose formation from alanine in rabbit kidney cortex 
tubules. 
2. MATERIALS AND METHODS 
2.1. Animals 
Termond strain, male white rabbits (2-3 kg body weight) were used 
throughout. Animals were maintained on standard rabbit chow. 
2.2. Preparation and incubation of kidney-cortex tubules 
Renal cortex tubules from rabbits were isolated using basically the 
procedures of Burg and Orloff 1121 and Guder et al. [13] as described 
previously [14]. The dry weight of tubules was determined according 
to Krebs [IS]. Isolated kidney tubules (10-13 mg dry weight) were in- 
cubated at 37°C in 2 ml of Krebs-Henseleit bicarbonate solution in 25 
ml plastic Erlenmeyer flasks with the rubber stoppers under the at- 
mosphere of 95% 02 + 5% Cot. Substrates were used at concentra- 
tions given in legends to tables and figure. Reactions were stopped by 
the addition of 35% HC104 (0.1 volume of suspension). 
The isotopic studies used for investigation of the contribution of 
alanine and 2-oxoglutarate to glucose formation were performed ac- 
cording to Exton and Park [3] and Pifkis et al. [16] following the treat- 
ment of samples with glutaminase. 
2.3. determination of metaboiiies 
Glucose, pyruvate, 2-oxoglutarate and alanine were determined in 
the deproteinized and neutralized samples. Glucose was measured 
with either glucose oxidase and peroxidase [17] or hexokinase and 
glucose 6-phosphate dehydrogenase [IS]. 2-Oxogtutarate was 
estimated spectrophotometrically according to Williamson and Cor- 
key [19]. For assay of pyruvate the standard enzymatic method was 
used [18] while alanine determination was performed with the T339 
Mikrotechna amino acid analyzer (Czechoslovakia). 
2.4. Enzymes and chemicals 
Collagenase (EC 3.4.24.3), type IV, was obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). L-Alanine was from Reanal 
~bt~hed by Etsevier Science ~bt~hers B. V. ~~iomedieat Rivision) 
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Factory of Laboratory Chemicals (Budapest, Hungary). L-[U-r4C]- 
alanine was from Amersham Earle Corporation (England) whereas 
[U-r4C]2-oxoglutarate was produced from L-[U-t4C]glutamate (In- 
stitute for Research Production and Uses of Radioisotopes, Prague, 
Czechoslovakia) with the use of aspartate aminotransferase (EC 
2.6.1.1, Boehringer, FRG) and limited amounts of oxaloacetate. The 
reaction mixture consisted of 50 mM triethanolamine-HCl buffer (pH 
7.4), 1 mM L-[U-%]glutamate (50 mCi/mmol), 0.5 mM oxalo- 
acetate and 50 units of aspartate aminotransferase/ml. On 2 h incuba- 
tion at room temperature the reaction was terminated by the addition 
of 1 M HCl. The protein was removed by centrifugation and superna- 
tant was subjected to cation-exchange chromatography on Dowex 
5OW-X8, H + , as described by Elsas et al. [20] for radiolabelled 
branched-chain 2-ketoacids. Column effluent fractions were collected 
and the r4C fractions were pooled. The [‘4C]2-oxoglutarate contained 
in the pooled fraction was then converted to its sodium salt, lyophiliz- 
ed and stored desiccated at -20°C. A single vial was reconstituted for 
each experiment and discarded after use. 
Other chemicals were of analytical grade. 
3. RESULTS AND DISCUSSION 
3.1. Glucose synthesis and substrate utilization 
In agreement with data for guinea pig renal cortex 
tubules [7,10] and perfused rat kidney [5] in isolated 
rabbit renal cortex tubules there is no glucose produc- 
tion from alanine added as a sole substrate (cf. table 1). 
However, in contrast Friedrichs and Schoner’s [6] find- 
ings in rat renal tubules, isolated rabbit renal tubules, 
just like dog [9] and guinea pig kidney cortex tubules 
[7,10], utilize alanine from the incubation medium, 
while aminooxyacetate, a potent inhibitor of 
aminotransferases [21], abolishes this process. Since 
alanine is considered to be an important substrate for 
glutamine formation [7,10], it seems likely that no 
glucose accumulation occurring during the metabolism 
of alanine in rabbit renal tubules might be due to 
utilization of pyruvate arising from the transamination 
of alanine as the source of 2-oxoglutarate required for 
the transamination of alanine. This implies that, under 
these conditions, pyruvate carboxylase which catalyses 
the fixation of CO2 on pyruvate to give oxaloacetate 
needed for the synthesis of citrate and then of aconitate 
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Fig. 1. Effect of 5 mM alanine on glucose formation in rabbit renal 
tubules incubated in the presence of various concentrations of 
2-oxoglutarate. Data represent values of a typical experiment. 
and 2-oxoglutarate, is involved in the conversion of 
alanine into glutamine rather than in the conversion of 
alanine into glucose [lo]. Accumulation of both 
glutamate and glutamine in the rabbit renal tubule 
suspension incubated with alanine, stimulated 2-3-fold 
on the addition of 5 mM 2-oxoglutarate (results not 
presented), is in agreement with this proposal. 
As shown in fig. 1, alanine alters the rate of gluco- 
neogenesis in the presence of 2-oxoglutarate depending 
upon the concentration of this ketoacid in the reaction 
mixture. At low concentrations of 2-oxoglutarate (be- 
tween 0.25 and 1.0 mM) 5 mM L-alanine decreases the 
rate of glucose formation, whereas at concentrations of 
2.5-10 mM this amino acid significantly stimulates this 
process. Moreover, aminooxyacetate abolishes both the 
inhibitory and stimulatory effects of alanine on glucose 
Table 1 
Glucose formation and substrate utilization in rabbit renal tubules incubated with L-alanine and/or 
2-oxoglutarate @mol/h per g dry weight) 
L-Alanine 2-Oxoglutarate AOA Glucose L-Alanine 2-Oxoglutarate 
(5 mM) (mM) (0.2 mM) formation utilization uptake 
- - 
0.5 - 
5.0 - 
_ + 
0.5 _ 
0.5 f 
5.0 _ 
5.0 + 
0.9 f 0.2 (7) 
16.8 f 2.8 (5) 
22.6 + 4.4 (7) 
0.4 f 0.1 (3) 
4.1 f 1.1 (5)bn’ 
18.4 * 2.7 (3)” 
32.5 f 4.9 (7)bVc 
25.2 + 3.0 (3Y’ 
180.0 f 17.0 (3) - 
_ 83.4 f 11.4 (4) 
- 146.7 + 9.4 (4) 
13.0 * 2.1 (3) - 
182.6 + 23.2 (3) 91.2 f 12.3 (4) 
21.0 + 2.7 (3)a - 
381.8 f 13.2 (3) 479.4 * 18.6 (4)C 
23.0 * 4.9 (3Y - 
a P< 0.01 versus corresponding control without AOA 
b P<O.Ol versus corresponding control with alanine alone 
b P<O.Ol versus corresponding control with 2-oxoglutarate alone 
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Table 2 
The effect of 2-oxoglutarate on the incorporation of L-[U-%]alanine into glucose (A) and the influence 
of unlabelled L-alanine on the incorporation of [U-t4C]2-oxoglutarate into glucose (B) 
Expt “C-labelled substrate Unlabelled substrate AOA [14C]Glucose 
(0.2 mM) (070 of control) 
A 5.0 mM [U-t4C]Alanine 0.5 mM 2-Oxoglutarate - 
5.0 mM [U-‘4C]Alanine 
812 f 77 (3)a 
0.5 mM 2-Oxoglubrate + 
5.0 mM [WL4C]Alanine 
111 + 9 (2) 
5.0 mM 2-Oxoglutarate _ 2655 + 389 (3)a 
5.0 mM [U-‘4C]Alanine 5.0 mM 2-Oxoglutarate + 84 + 11 (2) 
B 0.5 mM [U-t4C]2-Oxoglutarate 5.0 mM Alanine - 35 f 2 (3)a 
0.5 mM [U-t4C]2-Oxoglutarate 5.0 mM Alanine + 105 + 12 (2) 
5.0 mM [U-t4C]2-Oxoglutarate 5.0 mM Alanine - 110 * 8 (3) 
5.0 mM [U-t4C]2-Oxoglutarate 5.0 mM Alanine + 99 f 6 (2) 
Incubations were carried out for 60 min. The rates of incorporation of the “C-labelled substrates into 
glucose are expressed as means of percentage of control without 2-oxoglutarate (A) and without L-alanine 
(B) of number experiments hown in parentheses. The values for the basal rates of [‘4C]glucose produc- 
tion from [U-t4C]alanine and from 0.5 and 5 mM [U-‘4C]2-oxoglutarate added as the sole substrates were 
0.4 f 0.1, 15.5 r 2.1 and 21.2 + 2.2pmol/h per g dry weight, respectively 
a P<O.Ol versus corresponding control with no unlabelled substrate 
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production in the presence of 2-oxoglutarate as well as 
alanine utilization from the reaction medium (table 1). 
An inhibition by alanine of gluconeogenesis from 0.5 
mM 2-oxoglutarate results probably from a competi- 
tion for 2-oxoglutarate between alanine aminotransfer- 
ase and 2-oxoglutarate dehydrogenase and/or utiliza- 
tion of oxaloacetate generated via pyruvate carboxylase 
predominantly for citrate and then 2-oxoglutarate syn- 
thesis and not for phospoenolpyruvate production. In 
contrast, at 5 mM 2-oxoglutarate concentration glucose 
may be produced from both exogenous 2-oxoglutarate 
as well as pyruvate generated by alanine aminotrans- 
ferase. An increase of pyruvate content in the reaction 
medium from 1.1. + 0.9 in the presence of alanine 
alone up to 4.0 + 0.3 and 200.3 -I- 20.6 rmol/g dry 
weight upon 60 min of incubation of tubule suspension 
with 0.5 and 5 mM 2-oxoglutarate, respectively, is in 
agreement with this suggestion. Moreover, 2-oxoglu- 
tarate added at 0.5 mM concentration does not affect 
alanine utilization from the reaction medium, whereas 
in the presence of 5 mM 2-oxoglutarate the uptake of 
both ketoacid and alanine is markedly enhanced. 
3.2. The contribution of alanine and 2-oxoglutarate to 
gluconeogenesis 
In order to prove the suggestion that alanine may be 
converted to glucose in the presence of 2-oxoglutarate 
we have checked incorporation of both L- 
[U-14C]alanine and [U-14C]2-oxoglutarate into glucose 
under conditions studied. As shown in table 2, 
2-oxoglutarate at both 0.5 and 5 mM concentrations 
stimulates the incorporation of 5 mM [U-14]alanine to 
glucose B- and 26-fold, respectively, whereas aminooxy- 
acetate abolished this process. On the other hand, 
nonlabelled alanine decreases an incorporation of 0.5 
mM [U-14C]2-oxoglutarate into glucose by about 65070, 
probably due to utilization of 2-oxoglutarate predo- 
minantly for both glutamate and glutamine synthesis. 
At 5 mM concentration of [U-14C]2-oxoglutarate 
alanine does not affect the contribution of ketoacid to 
gluconeogenesis in both the absence and presence of 
aminooxyacetate. 
In view of these results it is possible to suggest hat (i) 
in isolated rabbit renal tubules incubated with alanine 
as the sole substrate this amino acid is not used for 
Table 3 
Glucose formation and substrate utilization in rabbit renal tubules incubated with plasma alanine 
concentrations and/or various low 2-oxoglutarate concentrations” 
2-Oxogluta- Alanine Glucose formation Alanine uptake 2-Oxoglutarate uptake 
rate (mM) (0.4 mM) 
0.05 _ 0.2 + 0.1 - 5.4 f 1.0 
0.05 + 0.4 f 0.1s 19.7 + 1.7 9.2 + 0.3s 
0.1 - 0.5 f 0.1 - 7.8 + 0.8 
0.1 + 1.1 + 0.1s 28.7 k 2.9 14.6 + l.4b 
0.2 _ 1.0 It 0.1 _ 17.3 * 1.5 
0.2 + 2.4 + 0.2b 35.0 * 2.7 29.8 + 2.4b 
a Data are expressed as means * SE of 3 separate xperiments; pmol/g dry weight per 10 min 
b P<O.Ol versus corresponding control with no alanine 
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Table 4 
The effect of low 2-oxoglutarate concentrations on the incorporation of L-[U-‘4C]alanine used at 
physiological concentration (A) and the influence of unlabelled L-alanine on the incorporation of 
[U-r4C]2-oxoglutarate used at the same conditions (B) 
Expt r4C-labelled substrate Unlabelled substrate [r4C]Glucose (Ore of control) 
A 0.4 mM [U-14C]L-Alanine 0.05 mM 2-Oxoglutarate 2239 f 270 (3)a 
0.4 mM [U-14C]L-Alanine 0.1 mM 2-Oxoglutarate 5240 r 662 (3)a 
0.4 mM [UL4C]L-Alanine 0.2 mM 2-Oxoglutarate 12331 (1) 
B 0.05 mM [U-r4C]2-Oxoglutarate 0.4 mM L-Alanine 36 f 8 (3)a 
0.1 mM [U-‘4C]2-Oxoglutarate 0.4 mM L-Alanine 50 + 10 (3)” 
0.2 mM [U-‘4C]2-Oxoglutarate 0.4 mM L-Alanine 78 (1) 
Incubations were carried out for 10 min. The rates of incorporation of r4C-labelled substrates into t4C- 
labelled glucose are expressed as means f SE of percentage of corresponding control with either no unlabell- 
ed 2-oxoglutarate (Expt A) or without unlabelled L-alanine (Bxpt B). The values for the basal rates of 
[‘4C]glucose production from [U-14C]alanine and from 0.05, 0.1 and 0.2 mM [UL4C]2-oxoglutarate added 
as the sole substrates were 0.02 + 0.01, 0.16 f 0.01, 0.50 + 0.04 and 0.97 pmol/lO min per g dry weight, 
respectively 
a P<O.OOl vs corresponding control with either no unlabelled 2-oxoglutarate (Expt A) or no unlabelled L- 
Alanine (Expt B) 
glucose synthesis since oxaloacetate provided via 
pyruvate carboxylase is predominantly used for citrate 
and 2-oxoglutarate synthesis via the tricarboxylic acid 
cycle [lo] and (ii) in the presence of exogenous 
2-oxoglutarate alanine is utilized as a glucose precursor. 
According to Bauer et al. [22] alanine concentration 
in rabbit serum ranges from 152.6 to 793.4 ,umol/l and 
is generally higher in starved animals [23]. In order to 
check whether alanine may contribute to renal 
gluconeogenesis at low physiological concentrations of 
this amino acid, we have studied the effect of 0.4 mM 
alanine on glucose formation from low 2-oxoglutarate 
concentrations. Since to our knowledge there are no 
data available for 2-oxoglutarate concentrations in rab- 
bit serum, we have applied 0.05, 0.1 and 0.2 mM 
2-oxoglutarate, i.e., concentrations imilar to those of 
pyruvate, estimated by Goldstein [24] for the whole- 
blood in the abdominal aorta of rat. It appeared that 
although alanine was not used for gluconeogenesis 
when added as a sole substrate, on 10 min incubation of 
rabbit renal tubules this amino acid increases both 
gluconeogenesis and 2-oxoglutarate uptake about 
2-fold (table 3). Moreover, the incorporation of 
[i4C]alanine to glucose is about 22-, 52- and 123-fold 
higher in the presence of 0.05, 0.1 and 0.2 mM 
2-oxoglutarate, respectively, while [‘4C]ketoacid incor- 
poration into glucose is significantly decreased by 
alanine under conditions studied (table 4). Thus, the 
contribution of alanine to renal glucose synthesis in the 
presence of low extracellular 2-oxoglutarate, considered 
to be one of the major substrates for gluconeogenesis in
kidney [25] may be of physiological importance, 
especially in liver insufficiency or intoxication, since 
renal glucose formation was found to be increased 
under conditions of hepatic failure 1261. 
Similar to alanine, glycerol at concentrations up to 10 
mM is not utilized for gluconeogenesis n rabbit renal 
tubules, when applied as the sole substrate [27,28]. 
However, in the presence of other glucose precursors it 
is incorporated into glucose and is able to alter the rate 
of renal glucose production [28]. In view of these obser- 
vations it seems possible that the contribution of 
various substrates to glucose formation in kidneys 
established with the use of glucose precursors applied as 
sole substrates might be different from that estimated at 
physiological substrate concentrations found in the 
blood in the abdominal aorta. 
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